This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Glaxo's Bid for Human Genome Turns Hostile: Hot Trends

NEW YORK ( TheStreet) -- Popular searches on the Internet include GlaxoSmithKline (GSK - Get Report) as the company will go hostile with its $13-a-share cash tender offer for Human Genome Sciences (HGSI), taking its bid straight to shareholders this week.

The decision comes after Human Genome's board rejected Glaxo's $2.6 billion bid last month, saying it did not reflect the inherent value of the company. Glaxo stands by its bid, which represents an 81% premium. Glaxo has not indicated when the tender would be launched this week. When it is, it will remain open for 20 business days.

The two companies sell Benlysta together and currently are working on two other experimental drugs, which Glaxo would receive full rights to if it purchases Human Genome.

Carlsberg is trending after the brewer reported declining first-quarter earnings due to lower beer sales in Russia.

Growth in the Russian market has been weighed down by a 200% tax increase on beer put in place in 2010. Carlsberg, which owns the biggest brewer in the country, said it expects the market to return to modest growth this year as consumers stocked up on beer ahead of another tax increase.

Operating profit, excluding some items, fell 43% from the year before to 574 million kroner ($100 million) and missing estimates.

Carlsberg owns brands including Carlsberg, Tuborg and Baltika. It is the world's fourth-largest brewer.

The Federal Aviation Administration is another popular search. A government agency said it received claims by federal employees indicating the FAA took up to two years to address safety concerns.

The U.S. Office of Special Counsel outlined seven instances of the FAA taking too long or not responding efficiently enough to internal claims of safety violations. Violations include air traffic controllers sleeping on duty, not directing aircraft precisely and others.

The agency urged the FAA to improve its oversight of air safety. The FAA has said it is working on the cases brought to its attention and is prepared to take "aggressive action where necessary."

The chatter on Main Street (a.k.a. Google, Yahoo! and other search sites) is always of interest to investors on Wall Street. Thus, each day, TheStreet compiles the stories that are trending on the Web, and highlights the news that could make stocks move.

-- Written by Brittany Umar.
Brittany joined TV in November 2006 after completing a degree in Journalism and Media Studies at Rutgers College. Previously, Brittany interned at the local ABC affiliate in New York City WABC-TV 7 where she helped research and produce On Your Side, a popular consumer advocacy segment.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GSK $43.29 0.00%
AAPL $93.64 0.00%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $241.80 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs